-
99.9% HIV-Free! Lenacapavir Shows Outstanding Results in Long-Acting PrEP Trial
Key Data from the PURPOSE 2 Trial PURPOSE 2 is a Phase III, double-blind, multicenter, randomized study comparing the safety and efficacy of Lenacapavir administered as a subcutaneous injection every…
-
Exclusive Interview with Dr. Huilai Zhang: A Detailed Look at the 5th Tianjin International Lymphoma Conference
From September 6 to 8, 2024, the 5th Tianjin International Lymphoma Conference was successfully held. The conference featured 12 specialized sessions, including immunotherapy, translational research, and new drug development, creating a platform that fosters international academic exchange and cooperation. During the event, Hematology Frontier had the privilege of interviewing the conference chair, Dr. Huilai Zhang…
-
Dr. Robert Negrin: An In-Depth Analysis of Immunomodulatory Mechanisms and Transplantation
In the field of hematopoietic stem cell transplantation (HSCT), immunomodulatory mechanisms play a crucial role, affecting not only the success rate of the transplant but also the recipient’s tolerance to the graft and their long-term health post-transplant. At the 12th Lu Daopei Hematology Academic Forum, Dr. Robert Negrin, former Chief of the Blood and Marrow…
-
ESMO 2024 | Dr. Gabriella Pravettoni: Physical Activity is Beneficial for Cancer Patients, But Also Challenging
Evidence from the Breast Cancer Customization Project suggests that a more comprehensive approach is needed to help patients find the motivation to adopt an active lifestyle. Physical activity is often recommended by clinicians as a lifestyle intervention to help prevent and manage non-communicable diseases, including cancer. It is also essential for the quality of life…
-
CCML 2024丨Dr. Xiaoling Ma: Setting Standards, Leveraging Technology, and Advancing Clinical Microbiology Testing Quality Across China
Infectious Disease Frontier: What do you think are the key highlights of this year’s CCML conference, and how do you believe they will positively influence clinical microbiology testing and infectious…
-
Gastroenterology丨Dr. Chuanlong Zhu: Analysis of a Rare Cause of Long-term Abnormal Liver Function in a Male Patient
Three pathogenic mutation sites in the SLC10A1 gene have been reported, among which c.800C＞T (p.Ser267Phe) is the most common mutation in China. This mutation significantly reduces the expression of sodium…
-
Dr. Yonghong Xiao: Responsibilities and Capacity Building of Infectious Disease Physicians
1. Infectious Diseases Infectious diseases are illnesses caused by pathogens, which include contagious and non-contagious diseases. Contagious diseases are defined as those caused by pathogens that have the potential to…
-
ESMO China’s Voice丨Dr. Jian Li’s Team Reports on Long-Term Follow-Up of the INTRIGUE China Bridging Study
Gastrointestinal stromal tumors (GIST) are mesenchymal tumors driven by mutations in oncogenes. In recent years, various types of small-molecule tyrosine kinase inhibitors (TKIs) have provided new treatment options for patients with advanced GIST, but there remains a significant unmet need in clinical care. During the 2024 ESMO Annual Meeting, Dr. Jian Li’s team from Peking…
Connecting Medical Expertise through Media